Eli Lilly's (LLY) experimental obesity drug, eloralintide, shows up to 11% weight loss in 12 weeks with minimal side effects in early-stage trial. Read more here.

Eli Lilly's experimental obesity drug, eloralintide, helped some patients lose 11.5% of their body weight at 12 weeks in an ...

While weight-loss aids have been around for decades, a new class of weight-loss drugs, including brands like Ozempic and Wegovy, has soared in popularity. Around one in eight American adults has used ...